BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8412201)

  • 1. Micronuclei: a potential intermediate marker for chemoprevention of aerodigestive tract cancer.
    Benner SE; Wargovich MJ; Lippman SM; Hong WK
    J Cell Biochem Suppl; 1993; 17F():250-4. PubMed ID: 8412201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of chemopreventive agents for lung and upper aerodigestive tract cancers.
    Kelloff GJ; Boone CW; Steele VK; Perloff M; Crowell J; Doody LA
    J Cell Biochem Suppl; 1993; 17F():2-17. PubMed ID: 8412195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology, biology, and chemoprevention of aerodigestive cancer.
    Lippman SM; Spitz M; Trizna Z; Benner SE; Hong WK
    Cancer; 1994 Nov; 74(9 Suppl):2719-25. PubMed ID: 7954292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinogen biomarkers related to smoking and upper aerodigestive tract cancer.
    Hecht SS; Carmella SG; Murphy SE; Foiles PG; Chung FL
    J Cell Biochem Suppl; 1993; 17F():27-35. PubMed ID: 8412204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoid chemoprevention of aerodigestive cancer: from basic research to the clinic.
    Ki Hong W; Lippman SM; Hittelman WN; Lotan R
    Clin Cancer Res; 1995 Jul; 1(7):677-86. PubMed ID: 9816032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention strategies: the relevance of premalignant and malignant lesions of the upper aerodigestive tract.
    Schantz SP
    J Cell Biochem Suppl; 1993; 17F():18-26. PubMed ID: 8412190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear retinoid acid receptor beta in bronchial epithelium of smokers before and during chemoprevention.
    Xu XC; Lee JS; Lee JJ; Morice RC; Liu X; Lippman SM; Hong WK; Lotan R
    J Natl Cancer Inst; 1999 Aug; 91(15):1317-21. PubMed ID: 10433621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprevention of premalignant lesions of the upper aerodigestive tract. Workshop, February 10-14, 1993, Amelia Island, Florida. Proceedings.
    J Cell Biochem Suppl; 1993; 17F():1-300. PubMed ID: 8412182
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduction in oral mucosa micronuclei frequency following alpha-tocopherol treatment of oral leukoplakia.
    Benner SE; Wargovich MJ; Lippman SM; Fisher R; Velasco M; Winn RJ; Hong WK
    Cancer Epidemiol Biomarkers Prev; 1994; 3(1):73-6. PubMed ID: 8118389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention strategies for lung and upper aerodigestive tract cancer.
    Benner SE; Lippman SM; Hong WK
    Cancer Res; 1992 May; 52(9 Suppl):2758s-2763s. PubMed ID: 1563008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micronuclei, a biomarker for chemoprevention trials: results of a randomized study in oral pre-malignancy.
    Benner SE; Lippman SM; Wargovich MJ; Lee JJ; Velasco M; Martin JW; Toth BB; Hong WK
    Int J Cancer; 1994 Nov; 59(4):457-9. PubMed ID: 7960211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermediate biomarkers in upper aerodigestive tract and lung chemoprevention trials.
    Benner SE; Hong WK; Lippman SM; Lee JS; Hittelman WM
    J Cell Biochem Suppl; 1992; 16G():33-8. PubMed ID: 1469903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers in chemoprevention for upper aerodigestive tract tumors.
    Shin DM; Ro JY; Hong WK
    Yonsei Med J; 1994 Jun; 35(2):113-31. PubMed ID: 8091788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micronuclei in bronchial biopsy specimens from heavy smokers: characterization of an intermediate marker of lung carcinogenesis.
    Benner SE; Lippman SM; Wargovich MJ; Velasco M; Peters EJ; Morice RC; Hong WK
    Int J Cancer; 1992 Aug; 52(1):44-7. PubMed ID: 1500226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogene mutations as intermediate markers.
    Sidransky D; Boyle J; Koch W; van der Riet P
    J Cell Biochem Suppl; 1993; 17F():184-7. PubMed ID: 8412191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk biomarkers and current strategies for cancer chemoprevention.
    Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC
    J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprevention of lung cancer.
    Hong WK
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):135-41. PubMed ID: 10550838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoprevention of aerodigestive epithelial cancers.
    Lippman SM; Hong WK
    Adv Exp Med Biol; 1992; 320():151-61. PubMed ID: 1442280
    [No Abstract]   [Full Text] [Related]  

  • 19. Strategies for phase II cancer chemoprevention trials: cervix, endometrium, and ovary.
    Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Steele VE; Lubet RA; Sigman CC
    J Cell Biochem Suppl; 1995; 23():1-9. PubMed ID: 8747372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoid modulation of biomarkers in oral leukoplakia/dysplasia.
    Beenken SW; Huang P; Sellers M; Peters G; Listinsky C; Stockard C; Hubbard W; Wheeler R; Grizzle W
    J Cell Biochem Suppl; 1994; 19():270-7. PubMed ID: 7823600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.